Stock Region Watchlist
Healthcare headaches & GM’s bold bet 🚗💊
Healthcare headaches & GM’s bold bet 🚗💊
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following information is for educational purposes only and does not constitute financial advice. Trading stocks involves risk, and you should always do your own research or consult with a qualified financial advisor before making investment decisions.
What a Tuesday morning. If you’ve been keeping an eye on the healthcare sector, it’s safe to say we’re feeling a little queasy this morning—and unfortunately, that’s not something a doctor can fix easily. While the insurers are taking a beating, the auto industry is revving its engine in a way that’s actually pretty exciting.
Let’s dive into the chaos and the opportunities together. Grab your coffee; we’re all going to need it.
📉 The Healthcare Hangover
We honestly can’t remember the last time we saw such a visceral reaction to regulatory news. The government dropped a bombshell on Medicare Advantage payments, and the market is not happy about it.
Humana ($HUM)
Current vibe: Ouch.
Humana is getting absolutely hammered, down 13.5% to $228. Here’s the deal: everyone was expecting a nice, cushy 5% increase in Medicare Advantage payments for 2027. Instead? They got a meager 0.09%. That is… negligible. It’s basically a rounding error.
Since Medicare Advantage is over half of Humana’s business, this hurts them more than anyone else. They are trading near 52-week lows, and honestly, it’s hard to watch.
Our take: It’s ugly right now, but let’s zoom out. Analysts still have price targets up to $353. For those with a stomach of steel and a long time horizon, this could be a massive discount. But short term? Watch out. If it breaks below $217.95, it could get even uglier.
UnitedHealth ($UNH)
Current vibe: Guilty by association.
UnitedHealth is down 15%, but we think the market might be overreacting here just a tad. Yes, they have the same Medicare headwinds (that 0.09% increase affects their 8.4 million members too). And yes, they projected a revenue dip for 2026.
However, UNH is a beast. They have nearly 50 million members and a diversified portfolio that Humana doesn’t quite match. Their EPS guidance is still on track.
Our take: This feels like a “throw the baby out with the bathwater” situation. UnitedHealth is a fortress. If they can manage costs, this dip might look like a gift in hindsight.
🚗 General Motors ($GM) Shifts Gears
Finally, some good news! While healthcare is on life support, GM is out here flexing.
General Motors ($GM)
Current vibe: Confidence.
GM just announced they are boosting their dividend by 20% and launching a $6 billion share buyback program. That is a company telling investors, loud and clear, “We have cash, and we know what to do with it.”
Sure, they took a hit in Q4 because of EV realignment costs (electric vehicles are hard, folks), but their 2025 earnings beat expectations. They are projecting massive cash flow for 2026—up to $23 billion.
Our take: We love a good dividend hike. It shows management believes in their future cash flow. For income-focused investors, GM is looking mighty tasty right now. Keep an eye on $83.77; if it breaks that, we could see a nice run.
The market is moody today. Healthcare is in the penalty box, but that’s where contrarian investors often find gold. Meanwhile, old-school auto is proving it can still print money.
Let’s stay disciplined out there!
- The Stock Region Team
Disclaimer: Stock Region is not a registered investment advisor. The content of this newsletter is provided for informational and entertainment purposes only. All investments carry risk, including the loss of principal. Past performance is not indicative of future results.


The Medicare Advantage rate announcement getting treated like an apocalypse when its basically flat funding shows how much these insurers were banking on guaranteed growth. The 0.09% vs expected 5% gap is wild and really exposes the dependence on govt subsidies for these private plans. Been following this space for a bit and the overreaction feels like a buying oportunity if UNH can weather the storm.